ASCO Annual Meeting: Sarcoma | Conference

Pimitespib Improved PFS Compared to Placebo for Advanced Refractory GIST
June 08, 2021

Pimitespib significantly improved progression-free survival while prolonging overall survival compared with placebo to treat patients with advanced gastrointestinal stromal tumor.

Benefit Observed With Catequentinib to Treat Advanced Synovial Sarcoma
June 05, 2021

Patients with advanced synovial sarcoma who received treatment with catequentinib experienced improved disease control and progression-free survival compared with dacarbazine.

Synovial Sarcoma Sees Impressive Responses With T-Cell Therapy Afamitresgene Autoleucel
June 05, 2021

Results of the phase 2 SPEARHEAD-1 trial were presented at the 2021 ASCO Annual Meeting, with a high overall response rate reported with afamitresgene autoleucel in advanced synovial sarcoma or myxoid/round cell liposarcoma.